| 证券代码：603108 | 证券简称：润达医疗 | 公告编号：临 | 2026-008 | | --- | --- | --- | --- | | 转债代码：113588 | 转债简称：润达转债 | | | 上海润达医疗科技股份有限公司 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 上海润达医疗科技股份有限公司（以下简称"本公司"或"公司"）股票 （股票简称：润达医疗 股票代码：603108）于 2026 年 1 月 8 日、1 月 9 日、1 月 12 日连续三个交易日内日收盘价格涨幅偏离值累计超过 20%，属于股票交易 异常波动。 经本公司自查，并向本公司控股股东核实，不存在应披露而未披露的重 大信息。 一、股票交易异常波动的具体情况 二、公司关注并核实的相关情况 1、生产经营情况 经自查，公司目前生产经营正常，公司经营情况及内外部经营环境没有发生 重大变化。 2、重大事项情况 经公司自查，并向公司控股股东书面征询核实：不存在关于公司的应披露而 未披露的重大事项，包括但不限于重大 ...

上海润达医疗科技股份有限公司 董事会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 上第六届董事会第一次会议通知于2026年1月7日以邮件形式发出，会议于 2026年1月12日（星期一）下午1:00-2:00在上海市虹口区乍浦路89号星荟中心1 座8楼公司会议室以现场及通讯相结合的方式召开。会议应到董事11人，实到董 事11人（其中董事赵斌、姚沈杰、王晶晶、金盈、朱明伟因工作原因以通讯方式 参会），公司高级管理人员廖上林列席了会议。会议由公司董事长张诚栩先生主 持。 本次董事会经过了适当的通知程序，会议的召集、召开和表决程序符合《中 华人民共和国公司法》等相关法律法规和公司章程的规定，会议及通过的决议合 法有效。 二、董事会会议审议情况 本次会议审议并通过如下议案： | 证券代码：603108 | 证券简称：润达医疗 | 公告编号：临 2026-007 | | --- | --- | --- | | 转债代码：113588 | 转债简称：润达转债 | | 同意聘任胡震宁先生、陆晓艳女士为公司副 ...

Market Performance - The pharmaceutical commercial sector increased by 0.8% on January 12, with RunDa Medical leading the gains [1] - The Shanghai Composite Index closed at 4165.29, up 1.09%, while the Shenzhen Component Index closed at 14366.91, up 1.75% [1] Top Gainers - RunDa Medical (603108) closed at 19.47, up 8.53%, with a trading volume of 1.0956 million shares and a transaction value of 2.123 billion [1] - Jia Shi Tang (002462) closed at 17.13, up 6.33%, with a trading volume of 441,200 shares and a transaction value of 733 million [1] - Yao Yi Gou (300937) closed at 38.42, up 4.54%, with a trading volume of 127,500 shares and a transaction value of 480 million [1] Top Losers - Nanjing Pharmaceutical (600713) closed at 5.43, down 1.63%, with a trading volume of 284,200 shares and a transaction value of 154 million [2] - Zhong Yao Holdings (000950) closed at 6.24, down 1.11%, with a trading volume of 740,900 shares and a transaction value of 461 million [2] - Ying Te Group (000411) closed at 12.81, down 1.08%, with a trading volume of 187,000 shares and a transaction value of 239 million [2] Capital Flow - The pharmaceutical commercial sector experienced a net outflow of 234 million from institutional investors and 184 million from speculative funds, while retail investors saw a net inflow of 417 million [2] - RunDa Medical had a net inflow of 123 million from institutional investors, but a net outflow of 171 million from speculative funds [3] - Jia Shi Tang experienced a net inflow of 80.845 million from institutional investors, with a net outflow of 28.7836 million from speculative funds [3]

资料显示，上海润达医疗科技股份有限公司位于上海市虹口区乍浦路89号星荟中心1座8楼，成立日期 1999年1月6日，上市日期2015年5月27日，公司主营业务涉及通过自有综合服务体系向各类医学实验室 提供体外诊断产品及专业技术支持的综合服务。主营业务收入构成为：试剂及其他耗材93.50%，仪器 3.70%，软件开发及服务2.67%，其他(补充)0.14%。 1月12日，润达医疗涨5.07%，截至发稿，报18.85元/股，成交4989.32万元，换手率0.44%，总市值 113.79亿元。 华西研究精选混合发起A（020444）基金经理为刘佳妍。 截至发稿，刘佳妍累计任职时间63天，现任基金资产总规模5237.37万元，任职期间最佳基金回报 2.44%， 任职期间最差基金回报2.34%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 责任编辑：小浪快报 从基金十大重仓股角度 数据显示，华西基金旗下1只基金重仓润达医疗。华西研究精选混合发起A（020444）三季度持有股数 1 ...

Market Performance - The pharmaceutical commercial sector increased by 1.32% on January 9, with RunDa Medical leading the gains [1] - The Shanghai Composite Index closed at 4120.43, up 0.92%, while the Shenzhen Component Index closed at 14120.15, up 1.15% [1] Top Gainers - RunDa Medical (603108) closed at 17.94, up 9.99% with a trading volume of 846,200 shares [1] - Huaren Health (301408) closed at 22.17, up 9.97% with a trading volume of 627,800 shares [1] - Shangyu Pingmin (301017) closed at 17.24, up 7.75% with a trading volume of 336,500 shares [1] Other Notable Stocks - Zhongyao Holdings (000950) closed at 6.31, up 5.87% with a trading volume of 1,147,000 shares [1] - Saily Medical (603716) closed at 27.83, up 4.39% with a trading volume of 783,100 shares [1] Market Capital Flow - The pharmaceutical commercial sector experienced a net outflow of 122 million yuan from institutional investors and 174 million yuan from speculative funds, while retail investors saw a net inflow of 296 million yuan [2] - The trading volume and turnover for various stocks indicate a mixed sentiment among different investor categories [2] Individual Stock Fund Flow - RunDa Medical had a net inflow of 2.30 billion yuan from institutional investors, while it faced a net outflow of 1.36 billion yuan from speculative funds [3] - Zhongyao Holdings saw a net inflow of 61.04 million yuan from institutional investors, with a net outflow of 62.93 million yuan from retail investors [3] - The overall fund flow indicates varying levels of confidence among different investor types in the pharmaceutical sector [3]

Group 1 - Huawei Pangu concept stock increased by 4.47%, ranking 8th in concept sector gains, with 27 stocks rising, including Yidian Tianxia at 20% limit up and Rundat Medical at limit up, while Hanxin Technology and Beixin Source saw declines of 2.01% and 0.75% respectively [1] - The top gaining concept sectors included Xiaohongshu concept at 6.21%, Kuaishou concept at 6.06%, and DRG/DIP at 5.67%, while POE film and glyphosate saw declines of -0.68% and -0.44% respectively [2] - The Huawei Pangu concept sector attracted a net inflow of 1.347 billion yuan, with 19 stocks receiving net inflows, and 6 stocks seeing inflows exceeding 50 million yuan, led by Yidian Tianxia with a net inflow of 732 million yuan [2] Group 2 - The top stocks in the Huawei Pangu concept by net inflow ratio included Rundat Medical at 15.01%, Bohan Technology at 14.91%, and Yidian Tianxia at 11.92% [3] - The trading performance of key stocks showed Yidian Tianxia with a daily increase of 20.00% and a turnover rate of 31.68%, while Rundat Medical and Bohan Technology increased by 9.99% and 7.70% respectively [3][4] - Other notable stocks included Tuoer Si with a 7.57% increase and a turnover rate of 10.12%, while stocks like Huakai Yibai and Jiulian Technology also showed significant gains [4]

一、本次股份被冻结基本情况 上海润达医疗科技股份有限公司（以下简称"公司"）于近日获悉股东刘辉先生、朱文怡女士所持有公司 的部分股份被冻结，具体情况如下： ■ 登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 刘辉先生持有公司股份31,528,771股，占公司总股本的5.22%。本次冻结的股份数为9,000,000股，累计 冻结的股份数为11,904,000股，占其持股总数的37.76%，占公司总股本的1.97%。 ● 朱文怡女士持有公司股份31,158,509股，占公司总股本的5.16%。本次冻结的股份数为9,000,000股，累 计冻结的股份数为9,000,000股，占其持股总数的28.88%，占公司总股本的1.49%。 ● 刘辉先生及朱文怡女士为一致行动人，截至本公告日，两人合计持有公司股份62,687,280股，占公司 总股本10.38%。合计冻结的股份数为20,904,000股，占持股总数的33.35%，占公司总股本的3.46%。 注：公司可转债处于 ...

南财智讯1月8日电，润达医疗公告，股东刘辉本次被冻结股份900.00万股，占其持股总数的28.55%，占 公司总股本的1.49%；股东朱文怡本次被冻结股份900.00万股，占其持股总数的28.88%，占公司总股本 的1.49%。本次冻结原因为司法冻结，由宁波梅山保税港区涌瑞股权投资合伙企业（有限合伙）申请。 刘辉和朱文怡为一致行动人，合计持有公司股份6268.73万股，合计被冻结股份2090.40万股，占其合计 持股总数的33.35%，占公司总股本的3.46%。上述股份冻结事项不会导致公司实际控制人发生变更，亦 不会对公司经营产生重大影响。 ...

| 证券代码：603108 | 证券简称：润达医疗 | 公告编号：临 | 2026-006 | | --- | --- | --- | --- | | 转债代码：113588 | 转债简称：润达转债 | | | 上海润达医疗科技股份有限公司 股东股份冻结的公告 二、股东股份累计被冻结/标记情况 | 股东名称 | 持股数量 | 持股比例 | 累计被冻结 | 累计被标 记数量 | 合计占其所持 | 合计占公司 | | --- | --- | --- | --- | --- | --- | --- | | | （股） | | 数量（股） | （股） | 股份比例 | 总股本比例 | | 刘辉 | 31,528,771 | 5.22% | 11,904,000 | 0 | 37.76% | 1.97% | | 朱文怡 | 31,158,509 | 5.16% | 9,000,000 | 0 | 28.88% | 1.49% | | 合计 | 62,687,280 | 10.38% | 20,904,000 | 0 | 33.35% | 3.46% | 截至公告披露日，刘辉先生及朱文怡女士累计被冻结/标记股份情况如下： ...

Market Overview - The pharmaceutical commercial sector increased by 0.79% compared to the previous trading day, with Luyuan Pharmaceutical leading the gains [1] - The Shanghai Composite Index closed at 4082.98, down 0.07%, while the Shenzhen Component Index closed at 13959.48, down 0.51% [1] Top Gainers in Pharmaceutical Sector - Luyuan Pharmaceutical (002788) closed at 27.49, up 10.00% with a trading volume of 812,100 shares and a transaction value of 2.156 billion [1] - Saili Medical (603716) closed at 26.66, up 9.98% with a trading volume of 700,200 shares and a transaction value of 1.802 billion [1] - Dajia Weikang (301126) closed at 13.50, up 5.47% with a trading volume of 184,200 shares and a transaction value of 245 million [1] Other Notable Stocks - Run Da Medical (603108) closed at 16.31, up 5.23% with a trading volume of 378,400 shares and a transaction value of 614 million [1] - Huaren Health (301408) closed at 20.16, up 3.38% with a trading volume of 503,400 shares and a transaction value of 1.016 billion [1] Market Capital Flow - The pharmaceutical commercial sector experienced a net outflow of 94.4079 million from institutional investors, while retail investors saw a net inflow of 213 million [2] - The overall market showed a mixed trend with some stocks experiencing significant outflows from institutional and speculative funds [2] Individual Stock Fund Flow - Saili Medical (603716) had a net inflow of 304 million from institutional investors, but a net outflow of 108 million from speculative funds [3] - Run Da Medical (603108) saw a net inflow of 62.5499 million from institutional investors, while experiencing outflows from both speculative and retail investors [3] - Huaren Health (301408) had a net inflow of 41.8956 million from institutional investors, but a significant outflow of 64.016 million from retail investors [3]